Janssen’s Talvey receives positive CHMP opinion
The treatment is a monotherapy for treating adult patients with refractory or relapsed multiple myeloma
Read More
Tag: CHMP
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
Chronic kidney disease affects roughly 700 million patients worldwide
Read More
AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
The authorisation would include certain patients with refractory generalised myasthenia gravis
Read More
EU regulator recommends revoking approval for Novartis’ sickle cell disease drug
The EMA’s human medicines committee concluded that the benefits of Adakveo did not outweigh its risks
Read More
Positive opinion for Gilead’s Hepcludex
The vital recommendation ensures marketing authorisation for treating the hepatitis delta virus
Read More
Positive CHMP opinion for UCB’s bimekizumab
Therapy concerns the treatment of adults with axial spondyloarthritis and psoriatic arthritis
Read More
Positive CHMP opinion for Janssen’s AKEEGA
If approved company’s prostate cancer therapy will be the first dual-action tablet available in EU
Read More
CHMP issues positive opinion for CSL’s etranacogene dezaparvovec
Gene therapy involves adults with haemophilia B and brings renewed hope to patients across Europe
Read More
LEO Pharma receives positive CHMP opinion of Adtralza
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis
Read More
CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus
Therapy has been developed for the prevention of disease in infants
Read More
Aurinia receives positive CHMP opinion for Lupkynis
Therapy effectively treats adults with active lupus nephritis in Europe
Read More
AbbVie’s Rinvoq gains recommended approval by CHMP
CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
